Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 12/2019

01-12-2019 | Concise Research Reports

Uncitedness in the Top General Medical Journals

Authors: M. Hossein Nowroozzadeh, MD, Mohammad Salehi-Marzijarani, PhD

Published in: Journal of General Internal Medicine | Issue 12/2019

Login to get access

Excerpt

Uncited research has received much attention due to its extent and impact on scholarship.1 It has been claimed that articles without a single citation do not have any constructive effect on future research and might be a waste of resources.1 Thus, the percent of uncited articles in any given journal could be considered as a measure of abundance of low-impact articles within that journal, very much like the impact factor (IF) that serves as an index of average impact of all published papers in a given journal. …
Literature
1.
2.
2017 Journal Impact Factor, Journal Citation Reports (Clarivate Analytics, 2018).
3.
4.
Metadata
Title
Uncitedness in the Top General Medical Journals
Authors
M. Hossein Nowroozzadeh, MD
Mohammad Salehi-Marzijarani, PhD
Publication date
01-12-2019
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 12/2019
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05290-2

Other articles of this Issue 12/2019

Journal of General Internal Medicine 12/2019 Go to the issue

Original Research

Electronic Health Record Phenotypes for Identifying Patients with Late-Stage Disease: a Method for Research and Clinical Application

Concise Research Report

Training Primary Care Physicians to Serve Underserved Communities: Follow-up Survey of Primary Care Graduates

Concise Research Report

Gender Differences and Themes in Peer Nominations for Chief Resident: a Qualitative Analysis

Original Research

Food Insecurity and Chronic Disease in US Young Adults: Findings from the National Longitudinal Study of Adolescent to Adult Health

Original Research

Association between Physician Intensity of Antibiotic Prescribing and the Prescription of Benzodiazepines, Opioids and Proton-Pump Inhibitors to Nursing Home Residents: a Population-Based Observational Study

From the Editors' Desk

From the Editors’ Desk: Peer Review at JGIM
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits